Two hemoglobin variants with an alteration of the oxygen-linked chloride binding: Hb antananarivo [α1(NA1)Val→Gly] and Hb barbizon [β144(HC1)Lys→Met]

References

• Perutz M. F., Shih D. T.‐B., Williamson D. The chloride effect in human haemoglobin: a new kind of allosteric mechanism. J. Mol. Biol. 1994; 239: 555–560
   PubMed Web of Science ®Google Scholar
• O'Donnell S., Mandaro R., Schuster T. M., Arnone A. X‐ray diffraction and solution studies of specifically carbamylated human hemoglobin A. J. Biol. Chem. 1979; 254: 12204–12208
   PubMed Web of Science ®Google Scholar
• Nigen A. M., Manning J. M., Alben J. O. Oxygen‐linked binding sites for inorganic ions. J. Biol. Chem. 1980; 255: 5525–5529
   PubMed Web of Science ®Google Scholar
• Perutz M. F., Kilmartin J. V., Nishikura K., Fogg J. H., Butler P. J. G., Rollema H. S. Identification of residues contributing to the Bohr effect in human haemoglobin. J. Mol. Biol. 1980; 138: 649–670
   PubMed Web of Science ®Google Scholar
• Perutz M. F., Fermi G., Poyart C., Pagnier J., Kister J. A novel allosteric mechanism in haemoglobin: structure of bovine deoxyhaemoglobin, absence of specific chloride‐binding sites and origin of the chloride‐linked Bohr effect in bovine and human haemoglobin. J. Mol. Biol 1993; 233: 536–545
   PubMed Web of Science ®Google Scholar
• Schneider R. G., Barwick R. C. Electrophoretic mobilities of mutant hemoglobins and mutant globin chains. CRC Handbook Series in Clinical Laboratory Science, Section I: Hematology, R. M. Schmidt, V. F. Fairbanks. CRC Press, Boca Raton, FLUSA 1986; Vol IV: 125–139
   Google Scholar
• Alter B. P., Goff S. C., Efremov G. D., Gravely M. E., Huisman T. H. J. Globin chain electrophoresis: a new approach to the determination of the Gγ/Aγ ratio in fetal haemoglobin and to me studies of globin synthesis. Br. J. Haematol. 1980; 44: 527–534
   PubMed Web of Science ®Google Scholar
• Lacombe C., Riou J., Godard C., Rosa J., Galacteros F. Characterization approach of silent beta‐chain hemoglobin variants. Acta Haematol. 1986; 78: 119–122
   Web of Science ®Google Scholar
• Riou J., Godart C., Hurtrel D., Mathis M., Bimet C., Bardakdjian‐Michau J., Prehu C., Wajcman H., Galactéros F. Evaluation of cation‐exchange high‐performance liquid‐chromatography for presumptive identification of hemoglobin variants. Clin. Chem. 1997; 43: 34–39
   PubMed Web of Science ®Google Scholar
• Wajcman H., Ducrocq R., Riou J., Mathis M., Godart C., Prehu C., Galacteros F. Perfusion chromatography on reversed‐phase column allows fast analysis of human globin chains. Anal. Biochem. 1996; 237: 80–87
   PubMed Web of Science ®Google Scholar
• Wajcman H., Bardakdjian J., Ducrocq R. Structural characterization of abnormal hemoglobins from dried blood specimens in a neonatal screening program. Ann. Biol. Clin. 1993; 51: 867–870
   PubMed Web of Science ®Google Scholar
• Déon C., Promé J. C., Promé D., Francina A., Groff P., Kalmes G., Galactéros F., Wajcman H. Combining mass spectrometry methods allows characterization of human hemoglobin variants localized within αT9 peptide: identification of Hb Villeurbanne α89 (FG1) His→Tyr. J. Mass Spectrom. 1997; 32: 880–887
   PubMed Web of Science ®Google Scholar
• Kister J., Poyart C., Edelstein S. J. An expanded two‐state allosteric model for interaction of human hemoglobin A with non saturating concentrations of 2,3 diphosphoglycerate. J. Biol. Chem. 1987; 252: 12085–12091
   Google Scholar
• Abraham D. J., Wireko F. C., Randad R. S., Poyart C., Kister J., Bohn B., Liard J. ‐F., Kunert M. P. Allosteric modifiers of hemoglobin: 2‐‘4‐‘‘(3,5‐disubstituted anilino) carbonyl’ methyl’ phenoxy’‐2‐methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 1992; 31: 9141–9149
   PubMedGoogle Scholar
• Boissel J. P., Kasper T. J., Bunn H. F. Cotranslational amino‐terminal processing of cytosolic proteins. Cell‐free expression ofsite‐directed mutants ofhuman hemoglobin. J. Biol. Chem. 1988; 263: 8443–8449
   PubMedGoogle Scholar
• Zak S. J., Brimhall B., Jones R. T., Kaplan M. E. Hemoglobin Andrew‐Minneapolis α2Aβ2144 Lys→Asn: a new high‐oxygen‐afriniry mutant human hemoglobin. Blood 1974; 44: 543–549
   PubMed Web of Science ®Google Scholar
• Harano K., Harano T., Ueda S., Ohkushi T., Imai K. A new hemoglobin variant, Hb Mito ‘β144 (HC1) Lys→GIu’, with increased oxygen affinity. FEBS Letters 1985; 192: 75–78
   PubMed Web of Science ®Google Scholar
• Kister J., Barbadjian J., Blouquit Y., Bohn B., Galactéros F., Poyart C. Inhibition of oxygen‐linked anion binding in Hb Camperdown ‘α2β2104(G6)Arg→Ser’. Hemoglobin 1989; 13: 567–578
   PubMed Web of Science ®Google Scholar
• Wajcman H., Kister J., Promé D., Blouquit Y., Préhu C., Poyart C., Galactéros F. Interaction of two amino acid substitutions within the same β chain ofhuman hemoglobin: the examples of Hb Corbeil ‘β26(B8)Glu→Lys, β104(G6)Arg→Thr’ and Hb Villeparisis ‘β77(EF1) His→Tyr, β80(EF4)Asn→Ser’. Comptes Rendus Acad. Sci. Paris, Sciences de la vie/Life sciences 1995; 318: 785–794
   PubMed Web of Science ®Google Scholar
• Poyart C., Bureaux E., Arnone A., Bonaventura J., Bonaventura C. Structural and functional studies of Hemoglobin Suresnes (arg 141 α2 replaced by His β2). Consequences of disrupting an oxygen‐linked anion‐binding site. J. Biol. Chem. 1980; 255: 9465–9473
   PubMed Web of Science ®Google Scholar
• Vasseur C., Blouquit Y., Kister J., Promé D., Kavanaugh J. S., Rogers P. H., Guillemin C., Arnone A., Galactéros F., Poyart C., Rosa J., Wajcman H. Hemoglobin Thionville: an a‐chain variant with a substitution of a glutamate for valine at NA‐1 and having an acetylated methionine N‐terminus. J. Biol. Chem. 1992; 267: 12682–12691
   PubMed Web of Science ®Google Scholar